Stage IVA Oropharyngeal Squamous Cell Carcinoma Completed Phase 2 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0039579 (Stage IVA Oropharyngeal Squamous Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01256385Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyTreatment